This upregulation activates the BRAF/TP53BP1/RAD51 pathway, reducing DNA damage and fostering radioresistance.471 Conversely, METTL3 also enhances radioresistance by modulating the invasiveness and migratory capabilities of cancer cells. This evidence concerns the gene TP53BP1 and cancer.